Navigation Links
Study Reveals Better Results in Patients Suffering From Depression.

Patients suffer from various psychiatric disease and they throng the hospitals for treatment. Statistics show that a third of these people // suffer from mental depressions of different levels.

Drugs that are used to treat them had a lot of controversial opinion about them and hence a study was conducted to analyze the effect of these drugs on the patients.

The initial results were that the drugs showed better results in case of well-qualified white women. The patients seem to undergo better recovery in their first trail of antidepressants. Dr. Madhukar Trivedi at the University of Texas Southwestern Medical Center carried out this study, which was funded by the National Institute of Mental Health ($35 million).

But in the earlier times treating patients with depression was a very challenging task. The first set of antidepressants will not usually work with the patients and the doctors would have to mix and match various drugs in order to find the exact cure for the particular patient.

The study (STAR-D) involved monitoring of the doctors especially in the initial months of the antidepressant’s usage.

The main idea to go about with this study is that there were evidences proving that antidepressants on certain periods led to increased suicidal tendencies in children/teenagers.

The Food and Drug Administration (FDA) has ordered that the pharmaceutical companies include the risks of children on the product labels. The study also said that in the future they would analyze the adult risk of usage of these antidepressants.

The results of the study were that it did not show any suicidal tendencies among the subjects (3000) included in the study.

The STAR-D study, which is a six-year study, was analyzed in two steps.

In step one the patients were given a newer class of antidepressants of selective serotonin reuptakes (Celexa). It showed that white women who were well qualified and patients who suffered from less number of diseases recovered quickly with initial treatment than who had severe depression and a number of co-existing diseases.

Patients who were not cured moved to the second step where they were administered with different therapies for difficult to treat depressions.
'"/>




Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: